Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print RSS Feed

Breaking News

Gil Roth
January 21, 2013
Biocatalysis expertise successfully transferred  Read More »
Gil Roth
January 21, 2013
G-CON processing system will handle oral cholera vaccine  Read More »

January 18, 2013
Burgess brings extensive industry and leadership experience  Read More »

January 18, 2013
Add Nordic countries  Read More »

January 18, 2013
Gains cancer therapeutics expertise  Read More »

January 18, 2013
Thommes to head infectious disease research growth  Read More »

January 17, 2013
Arnold to lead product development and technical services  Read More »

January 17, 2013
Expands manufacturing for monoclonal antibodies  Read More »

January 17, 2013
Will use Xtend technology for therapeutic antibody  Read More »

January 17, 2013
To develop delivery platform for cancer treatments  Read More »

January 17, 2013
Paladin granted rights to market APN311 in Canada and Africa  Read More »

January 16, 2013
Program aims to drive adoption of best practices  Read More »

January 16, 2013
Serum Institute to produce cGMP grade vaccine product  Read More »

January 16, 2013
To explore inhaled delivery for pulmonary fibrosis drug  Read More »

January 16, 2013
Delivers second preclinical drug candidate  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On